Corey N. Fishman Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Corey N. Fishman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Corey N. Fishman. Corey N. Fishman is Director in BIOSPECIFICS TECHNOLOGIES CORP ($BSTCE) and Director in MOMENTA PHARMACEUTICALS INC ($MNTA) and COO & CFO in Durata Therapeutics, Inc. ($DRTX) and President & CEO in Iterum Therapeutics plc ($ITRM).
Latest Insider Trading Transactions of Corey N. Fishman
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BSTCE, DRTX, ITRM, MNTA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 15 2021 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Option Exercise | A | 0.00 | 430,000 | 0 | 430,000 | |
| Jan 27 2021 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Sell | S | 1.73 | 85,445 | 147,820 | 322,008 | 407.5 K to 322 K (-20.97 %) |
| Jan 27 2021 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Grant | A | 0.00 | 167,500 | 0 | 407,453 | 240 K to 407.5 K (+69.81 %) |
| May 04 2020 | BSTCE | BIOSPECIFICS TECHN ... | Fishman Corey N. | Director | Option Exercise | A | 55.63 | 6,000 | 333,780 | 6,000 | |
| Apr 15 2020 | BSTCE | BIOSPECIFICS TECHN ... | Fishman Corey N. | Director | Grant | A | 0.00 | 2,018 | 0 | 2,018 | 0 to 2 K |
| Jun 21 2019 | MNTA | MOMENTA PHARMACEUT ... | Fishman Corey N. | Director | Option Exercise | M | 0.00 | 4,356 | 0 | 0 | |
| Jun 21 2019 | MNTA | MOMENTA PHARMACEUT ... | Fishman Corey N. | Director | Option Exercise | A | 12.64 | 25,000 | 316,000 | 25,000 | |
| Jun 21 2019 | MNTA | MOMENTA PHARMACEUT ... | Fishman Corey N. | Director | Buy | M | 0.00 | 4,356 | 0 | 10,090 | 5.7 K to 10.1 K (+75.97 %) |
| Feb 19 2019 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Option Exercise | A | 5.80 | 150,000 | 870,000 | 150,000 | |
| Aug 21 2018 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Buy | P | 8.73 | 2,000 | 17,466 | 239,953 | 238 K to 240 K (+0.84 %) |
| Aug 21 2018 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Buy | P | 8.73 | 2,000 | 17,466 | 239,953 | 238 K to 240 K (+0.84 %) |
| Jun 25 2018 | MNTA | MOMENTA PHARMACEUT ... | Fishman Corey N. | Director | Option Exercise | M | 0.00 | 5,734 | 0 | 0 | |
| Jun 25 2018 | MNTA | MOMENTA PHARMACEUT ... | Fishman Corey N. | Director | Option Exercise | A | 0.00 | 4,356 | 0 | 4,356 | |
| Jun 25 2018 | MNTA | MOMENTA PHARMACEUT ... | Fishman Corey N. | Director | Option Exercise | A | 22.30 | 8,855 | 197,467 | 8,855 | |
| Jun 25 2018 | MNTA | MOMENTA PHARMACEUT ... | Fishman Corey N. | Director | Buy | M | 0.00 | 5,734 | 0 | 5,734 | 0 to 5.7 K |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Option Exercise | C | 0.00 | 1,591 | 0 | 0 | |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Option Exercise | C | 0.00 | 4,050 | 0 | 0 | |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Option Exercise | C | 0.00 | 33,259 | 0 | 0 | |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Buy | P | 13.00 | 3,000 | 39,000 | 237,953 | 235 K to 238 K (+1.28 %) |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Buy | C | 0.00 | 1,591 | 0 | 234,953 | 233.4 K to 235 K (+0.68 %) |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Buy | C | 0.00 | 4,050 | 0 | 233,362 | 229.3 K to 233.4 K (+1.77 %) |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Buy | C | 0.00 | 33,259 | 0 | 229,312 | 196.1 K to 229.3 K (+16.96 %) |
| May 29 2018 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Option Exercise | A | 13.00 | 127,307 | 1,654,991 | 127,307 | |
| Jun 22 2017 | MNTA | MOMENTA PHARMACEUT ... | Fishman Corey N. | Director | Option Exercise | A | 0.00 | 5,734 | 0 | 5,734 | |
| Jun 22 2017 | MNTA | MOMENTA PHARMACEUT ... | Fishman Corey N. | Director | Option Exercise | A | 17.20 | 11,207 | 192,760 | 11,207 | |
| Sep 26 2016 | MNTA | MOMENTA PHARMACEUT ... | Fishman Corey N. | Director | Option Exercise | A | 12.09 | 33,000 | 398,970 | 33,000 | |
| Jul 26 2012 | DRTX | Durata Therapeutic ... | Fishman Corey N. | COO & CFO | Option Exercise | C | 0.00 | 179,531 | 0 | 0 | |
| Jul 26 2012 | DRTX | Durata Therapeutic ... | Fishman Corey N. | COO & CFO | Option Exercise | P | 0.00 | 51,163 | 0 | 179,531 | |
| Jul 26 2012 | DRTX | Durata Therapeutic ... | Fishman Corey N. | COO & CFO | Buy | C | 0.00 | 22,441 | 0 | 22,441 | 0 to 22.4 K |
Page: 1